Jonathon C Arnold Selected Research

Jonathon C Arnold Research Topics

Disease

15	Epilepsy (Aura) 01/2023 - 01/2016
14	Schizophrenia (Dementia Praecox) 01/2019 - 08/2010
13	Myoclonic Epilepsies (Myoclonic Encephalopathy) 04/2024 - 11/2019
13	Seizures (Absence Seizure) 01/2023 - 01/2013
5	Psychotic Disorders (Schizoaffective Disorder) 05/2022 - 12/2012
4	Drug Resistant Epilepsy 01/2023 - 01/2021
3	Chronic Pain 01/2023 - 01/2019
3	Pain (Aches) 01/2023 - 01/2020
3	Neoplasms (Cancer) 08/2022 - 01/2012
3	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2012
2	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2023 - 01/2020
2	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 09/2022 - 01/2022
2	Substance-Related Disorders (Drug Abuse) 05/2022 - 10/2010
2	Wounds and Injuries (Trauma) 01/2022 - 01/2020
2	Vomiting 01/2020 - 01/2019
2	Body Weight (Weight, Body) 11/2011 - 01/2011
1	Necrosis 04/2024
1	Nervous System Diseases (Neurological Disorders) 01/2023
1	Mesothelioma 08/2022
1	Brain Diseases (Brain Disorder) 01/2022
1	Anxiety Disorders (Anxiety Disorder) 09/2021
1	Myocardial Infarction 01/2021
1	Neuroinflammatory Diseases 01/2020
1	Sudden Death 01/2020
1	Mood Disorders (Mood Disorder) 01/2020
1	Lennox Gastaut Syndrome 11/2019
1	Anorexia Nervosa 01/2019
1	Multiple Sclerosis 01/2019
1	Tourette Syndrome (Tourette's Syndrome) 01/2019
1	Nausea 01/2019
1	Tobacco Use Disorder (Nicotine Dependence) 12/2018
1	Back Pain (Backache) 01/2018

Drug/Important Bio-Agent (IBA)

16	CannabidiolIBA 01/2023 - 09/2008
13	Anticonvulsants (Antiepileptic Drugs)IBA 01/2023 - 11/2019
11	CannabinoidsIBA 01/2023 - 04/2008
8	Dronabinol (THC)FDA LinkGeneric 01/2021 - 04/2008
8	Neuregulin-1 (Neuregulin 1)IBA 01/2017 - 06/2011
5	EndocannabinoidsIBA 01/2023 - 06/2005
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2012
3	cannabigerolic acidIBA 01/2023 - 12/2021
3	cannabigerolIBA 08/2022 - 01/2021
3	Clobazam (HR 376)IBA 12/2021 - 11/2019
3	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2016 - 01/2012
2	Messenger RNA (mRNA)IBA 04/2024 - 09/2022
2	AcidsIBA 01/2023 - 11/2019
2	T-Type Calcium Channels (T-Type Calcium Channel)IBA 01/2023 - 01/2022
2	SodiumIBA 01/2023 - 06/2022
2	cannabichromeneIBA 01/2023 - 01/2021
2	Calcium Gluconate (CBG)IBA 08/2022 - 01/2022
2	Methamphetamine (Desoxyn)FDA LinkGeneric 05/2022 - 12/2012
2	Medical MarijuanaIBA 01/2020 - 01/2018
2	cannabidiolic acidIBA 01/2020 - 11/2019
2	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2016 - 01/2012
2	Serotonin (5 Hydroxytryptamine)IBA 01/2013 - 06/2005
2	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 08/2010 - 06/2005
1	ProstaglandinsIBA 04/2024
1	InterleukinsIBA 04/2024
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 04/2024
1	N-acylethanolaminesIBA 01/2023
1	AmidesIBA 01/2023
1	LipidsIBA 01/2023
1	ConvulsantsIBA 01/2023
1	Therapeutic UsesIBA 01/2023
1	MonoglyceridesIBA 01/2023
1	cannabidivarinic acidIBA 01/2023
1	Voltage-Gated Sodium ChannelsIBA 01/2023
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2023
1	RNA (Ribonucleic Acid)IBA 09/2022
1	Neurotransmitter Agents (Neurotransmitter)IBA 09/2022
1	Terpenes (Terpenoids)IBA 06/2022
1	EstersIBA 01/2022
1	olivetolic acidIBA 01/2022
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2022
1	3- (2- nitro- 1- phenylethyl)- 2- phenyl- 1H- indoleIBA 01/2022
1	ABX-1431IBA 01/2022
1	EnzymesIBA 09/2021
1	Citalopram FDA LinkGeneric 09/2021
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 09/2021
1	Anti-Anxiety Agents (Anxiolytics)IBA 09/2021
1	Escitalopram FDA Link 09/2021
1	TRPV1 receptorIBA 01/2021
1	SB 705498IBA 01/2021
1	OilsIBA 01/2021
1	Glycine Receptors (Glycine Receptor)IBA 01/2021
1	SolutionsIBA 01/2020
1	CytokinesIBA 01/2020
1	Aminobutyrates (Aminobutyric Acid)IBA 12/2019
1	ParvalbuminsIBA 01/2019
1	Complement System Proteins (Complement)IBA 01/2019
1	Opioid Analgesics (Opioids)IBA 12/2018
1	Antipsychotic Agents (Antipsychotics)IBA 10/2017
1	Clozapine (Clozaril)FDA LinkGeneric 10/2017
1	Dopamine (Intropin)FDA LinkGeneric 01/2017
1	Sigma-1 ReceptorIBA 12/2014
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2014

Therapy/Procedure

9	Induced Hyperthermia (Thermotherapy) 01/2023 - 01/2020
2	Therapeutics 01/2021 - 11/2019
1	Oral Administration 01/2020
1	Drug Therapy (Chemotherapy) 01/2019
1	Aftercare (After-Treatment) 02/2013